ClinicalTrials.govpublic full text
A Phase I/II Trial of the MUC1 Inhibitor, GO-203-2C in Patients With Relapsed or Refractory Acute Myeloid Leukemia
acute myeloid leukemia, in relapse, recurrent adult acute myeloid leukemia, refractory acute myeloid leukemia, relapsed acute myeloid leukemia, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 826900
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.